Stocktoria
Allogene Therapeutics, Inc. ALLO
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-11
Allogene Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 16,445,682 | $38.3M |
| CITADEL ADVISORS LLC | 6,887,120 | $16.8M |
| TWO SIGMA INVESTMENTS, LP | 5,375,456 | $13.1M |
| MILLENNIUM MANAGEMENT LLC | 3,322,053 | $8.1M |
| D. E. Shaw & Co., Inc. | 2,763,776 | $6.7M |
| AQR CAPITAL MANAGEMENT LLC | 2,484,780 | $6.1M |
| RENAISSANCE TECHNOLOGIES LLC | 2,139,328 | $5.2M |
| Point72 Asset Management, L.P. | 221,335 | $540,057 |
Source: SEC EDGAR filings · CIK 0001737287 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.